Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

March 2015 Issue of The Medicine Maker

Register to download

Register here to download any issue of The Medicine Maker for FREE.

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

Articles featured in this issue

Manufacture Small Molecules

Practical Innovation

| Charlotte Barker

Innovation in pharma isn’t synonymous with drug discovery

Manufacture Biosimilars

America’s Most Wanted: Biosimilars

| Charlotte Barker

It’s been a long road, but the FDA has finally given the nod to the first official biosimilar in the US

Discovery & Development Clinical Trials

Silent Data

| Stephanie Sutton

Information from “stalled” drug trials should be published, not tossed aside

Manufacture Small Molecules

Rewarding Humanity

| Stephanie Sutton

An antimalarial medicine-making project wins the inaugural Humanity in Science Award

Business & Regulation Business Practice

Mining Social Media

| Stephanie Sutton

New technology interprets slang and banter to find out what people really think

Business & Regulation Packaging

Personalized Labels

| Stephanie Sutton

Just how prevalent is pharmacogenomic information on European drug labels?

Discovery & Development Standards & Regulation

Premature Revelation

| Stephanie Sutton

FDA scolds company for revealing interim trial results

Business & Regulation Business Practice

Funding Dementia Discovery

| Stephanie Sutton

$100 million pledged to kick start investment in new research

Discovery & Development Formulation

Small Pharma

| Helen Sammons

Legislation on pediatric medicines is sowing the seeds for a better future, but we must maintain momentum if children are to get the best possible care.

Business & Regulation Business Practice

Supplying Health to the Whole World

| Natalie Privett

New and improved drugs are released every year to tackle global health needs – and many pharma companies have initiatives to supply those drugs to the developing world.

Manufacture Small Molecules

Kicking Batch Habits

| Richard Fazackerley

The industry has been dipping its toe into the water of continuous manufacturing for years. Are we finally ready to dive in?

Manufacture Business Practice

The Big Break for Biosimilars?

| Stephanie Sutton

The first US biosimilar has been pocketed and the game is on. We bring six experts to the table to discuss the impact on industry dynamics.

teaser of 0315-601
Discovery & Development Drug Delivery

Remote Controlled Drugs

The latest devices can deliver a drug in the right place and at the right time at the push of a button.

teaser of 0315-602
Discovery & Development Drug Delivery

Nonthreatening Needles

No-one likes getting injections. Fortunately, patients may soon have a pain-free alternative in the form of microneedle delivery systems

Business & Regulation Business Practice

The Challenge of China

As the world’s most populous country and the second largest global economy, the potential for growth is significant. But how does a company break into China?

Discovery & Development Clinical Trials

Advocate of Change

| Charlotte Barker

Sitting Down With… Phyllis Greenberger, President and CEO of the Society for Women’s Health Research (SWHR), Washington, D.C., USA.

Discovery & Development Drug Delivery

The Toolbox of 2025

| Charlotte Barker

Previously, in our series – “Connecting the Dots in Drug Delivery” – we examined the current status of drug delivery. We saw how today’s new therapeutics pose tough challenges for formulation scientists, and how companies are tackling those challenges.

teasee of 0315-902
Discovery & Development Analytical Science

A Sweet Revolution

| Sponsored by ThermoFisher Scientific

Glycan analysis poses major challenges for the biopharma industry; how can new technology lighten the load?

teaser of 0315-903
Manufacture Biosimilars

Monitoring Biosimilars

| Stephanie Sutton

We speak with Professor Begoña Calvo from University of the Basque Country in Spain to find out more about her research into pharmacovigilance for biosimilars.

Other issues of 2015